Bed Bath & Beyond Inc. (NASDAQ:BBBY) is expected to report its second quarter financial results on�Sept.25. The company will hold a conference call at�5.00pm�eastern time on the same day to discuss the results.
With 1,400 plus stores, Bed Bath & Beyond operates a chain of home-decor retailer under the names Bed Bath & Beyond in the United States and Canada, as well as, World Market, Cost Plus World Market, Christmas Tree Shops, and That!, Harmon, Harmon Face Values and buybuy BABY in the United States.
The quarterly results could help investors to gauge how well the improvement in the housing market is helping the company, which sells all sorts of housewares, home furnishings and bath items at everyday low prices.
In the quarterly results, investors could look for answers to questions such as the threat from online competition, an uncertain margin outlook, and the waning contribution from product trends like single-serve coffee.
Top Oil Service Stocks To Own For 2015: KYTHERA Biopharmaceuticals Inc (KYTH)
KYTHERA Biopharmaceuticals, Inc., incorporated in June 2004, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market. The Company�� initial focus is on the facial aesthetics market. The Company�� product candidate, ATX-101, is a injectable drug in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable double chin. Based on clinical trials conducted, ATX-101 has exhibited results in the reduction of submental fat. ATX-101 contains a synthetic form of sodium deoxycholate. In the United States and Canada, the Company is conducting two pivotal Phase III trials of ATX-101 for the reduction of submental fat. The Company initiated this pivotal Phase III clinical program, with planned enrollment of 1,000 patients, in March 2012.
In Europe, Bayer, its collaborator outside the United States and Canada, recently completed two pivotal Phase III trials of ATX-101 for the reduction of submental fat. In these multi-center, randomized, double-blind, placebo-controlled pivotal trials involving 723 patients, ATX-101 resulted in a reduction in submental fat, as assessed by a validated clinician scale and a patient satisfaction scale.
ATX-101 contains a synthetic form of sodium deoxycholate. ATX-101 is designed to be a locally-injected drug that causes proximal, preferential destruction of adipocytes, or fat cells, with minimal effect on surrounding tissue. Upon subcutaneous injection under the skin, ATX-101 disrupts cell membranes in protein-poor tissues, such as fat, while being attenuated by interactions with protein-rich tissue, such as skin, muscle and blood vessels. This attenuation by protein-rich tissue results in the preferential destruction of adipocytes by ATX-101. The destruction of adipocytes, or adipocytolysis, elicits a natural response, in which macrophages are attracted to remove cellular debris and fat particles t! hrough the lymphatic system. The macrophages also emit low levels of chemical messengers, known as cytokines, which attract fibroblasts, another cell type, to the area. Fibroblasts produce collagen, and it is believed that new collagen production, or neocollagenesis, promotes retraction of the skin in the areas of fat reduction. The fat removal process with ATX-101 is incremental with each treatment, thereby allowing for control of the aesthetic outcome.
Advisors' Opinion:- [By Lisa Levin]
Kythera Biopharmaceuticals (NASDAQ: KYTH) shares surged 24.40% to touch a new 52-week high of $41.71 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.
- [By Jake L'Ecuyer]
Equities Trading UP
Repros Therapeutics (NASDAQ: RPRX) shot up 29.82 percent to $27.60 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal庐. Shares of Kythera Biopharmaceuticals (NASDAQ: KYTH) got a boost, shooting up 26.04 percent to $42.26 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Aeropostale (NYSE: ARO) was also up, gaining 16.75 percent to $10.05 after private equity firm Sycamore Partners reported that it had bought a 7.96 percent stake in the company. - [By Lisa Levin]
Kythera Biopharmaceuticals (NASDAQ: KYTH) jumped 24.43% to $41.72 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.
- [By Lisa Levin]
Kythera Biopharmaceuticals (NASDAQ: KYTH) shares moved up 24.01% to $41.58. The volume of Kythera Biopharmaceuticals shares traded was 6431% higher than normal. Kythera reported positive ATX-101 top line phase III trial results for the reduction of submental fat.
Top 10 Low Price Companies To Own For 2014: Brady Corp (BRC)
Brady Corporation (Brady), incorporated in 1914, is an international manufacturer of identification solutions and specialty materials that identify and protect premises, products and people. Brady provides customers with a range of customized and diverse products for use in various applications. The Company is organized and managed on a geographic basis within three regions: Americas, Europe, the Middle East and Africa (EMEA), and Asia-Pacific, which are the segments. Across these regions, the Company operates three primary business platforms: Identification Solutions (ID Solutions), Direct Marketing and Die-Cut. During the fiscal year ended July 31, 2012 (fiscal 2012), the Company�� revenue included Americas 45%, EMEA 29% and Asia-Pacific 26% respectively. During fiscal 2012, the Company�� ID Solutions generated 56%, Direct Marketing 27% and Die-Cut 17% of revenue. In December 2012, Water Street Healthcare Partners sold Precision Dynamics Corporation (PDC) to the Company.
ID Solutions
Within the ID Solutions platform, Brady�� product categories include workplace safety and compliance, which includes facility identification, labeling systems, spill control, lockout/tagout, and software services; product identification, which includes materials and printing systems for product identification, brand protection labeling, work in process labeling, finished product identification, and bar coding that performs under a range of harsh or demanding conditions; wire identification, which includes handheld printers, wire markers, sleeves and tags, and people identification, which includes self-expiring name tags, badges, lanyards, and access control software and products. Approximately 75% of ID Solutions products are sold under the Brady brand.
Safety and facility identification products are also marketed under the Safety Signs Service brand, with some lockout/tagout products offered under the Scafftag brands. In the United States, identification products for the u! tility industry are marketed under the Electromark brand, and spill-control products are marketed under the Sorbent Products Company brand; security and identification badges and systems are included in the Temtec, B.I.G., Identicard/Identicam, STOPware, J.A.M. Plastics, PromoVision, and Brady People ID brands; wire identification products are marketed under the Modernotecnica brand in Italy and the Carroll brand in Australia; hand-held regulatory documentation systems are available under the Tiscor brand, and custom labels and nameplates are available under the Stickolor brand in Brazil.
The Company�� ID Solutions platform offers products with rapid response and superior service to provide solutions to customers. The business markets and sells products through multiple channels, including distributors, direct sales, mail-order-catalog marketing, and electronic access through e-commerce. The ID Solutions platform serves customers in many markets, which include industrial manufacturing, electronic manufacturing, chemical, oil, gas, food and beverage, aerospace, defense, mass transit, electrical contractors, and telecommunications, among others. The ID Solutions platform provides differentiated, products, many which have been internally developed and manufactured. These internally developed products include materials, printing systems, and software.
Direct Marketing
Within the Direct Marketing business platform, Brady�� product categories include workplace safety and compliance products, which include informational signs, tags, security and traffic related products, first aid supplies, material handling, asset identification, safety and facility identification, and regulatory products. Products within the Direct Marketing platform are sold under a range of brands, including safety and facility identification products offered under the Seton, Emedco, Signals, Safetyshop, Clement and Personnel Concepts brands; spill-control products under the D.A.W.G. brand, and ! first aid! supplies under the Accidental Health and Safety, Trafalgar, and Securimed brands. The Direct Marketing platform markets and sells products through multiple channels, which include catalog, telemarketing and e-commerce. The business serves customers in many markets, which include process industries, manufacturers, government, education, construction, and utilities. The Direct Marketing platform manufactures a range of stock and custom identification products, and also sells a range of related resale products.
Die-Cut
Within the Die-Cut business platform, the Company's products include customized precision die-cut products used to seal, dissipate heat, insulate, protect, shield, or provide other mechanical performance properties. Products within the Die-Cut platform are sold primarily under the Brady brand, with some European business marketed as Balkhausen products. The business sells through a technical direct sales force, and is supported by global strategic account management. The Die-Cut platform serves customers in many markets, which include mobile handset, hard disk drive, consumer electronics, other computing devices, as well as products for the automotive and medical equipment markets. The Die-Cut platform consists of engineered customized products, manufactured to specific customer requirements.
Advisors' Opinion:- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Brady (NYSE: BRC ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Brady doing by this quick checkup? At first glance, OK, it seems. Trailing-12-month revenue increased 1.7%, and inventory decreased 6.1%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue shrank 7.8%, and inventory shrank 6.1%. Over the sequential quarterly period, the trend looks healthy. Revenue dropped 5.7%, and inventory dropped 20.2%. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Brady (NYSE: BRC ) , whose recent revenue and earnings are plotted below. - [By Ben Levisohn]
Brady (BRC) has gained 1.7% to $28.38 after it was upgraded to Buy from Underperform at Merill Lynch.
Aeropostale (ARO) has gained 6.3% to $3.55 for no apparent reason, at least one I haven’t been able to find yet.
Top 10 Low Price Companies To Own For 2014: Opus International Consultants Ltd (OIC)
Opus International Consultants Limited is a supplier of multidisciplinary consultancy and project management services across a range of disciplines including, civil, mechanical and electrical engineering, and planning, environmental, architectural and property management. The Company operates in four segments: New Zealand, United Kingdom, Australia and Canada. Services supplied support asset development and asset management activities of the Company�� clients. Asset management services include property management and asset maintenance services predominantly using our engineering and environmental specialists. Asset development services include civil, mechanical and electrical engineering, planning, environmental and architectural work. Effective September 3, 2013, Opus International Consultants Ltda majority-owned unit of Opus Group Bhd acquired Stewart, Weir & Co Ltd. Advisors' Opinion:- [By John McCamant]
Nektar Therapeutics (NKTR) is expected to get FDA approval this year for its lead drug naloxegol, a once-a-day pill for opioid-induced constipation (OIC). The drug is licensed to AstraZeneca. NKTR will receive up to $245 million in milestone payments, plus royalties.
Top 10 Low Price Companies To Own For 2014: Alpha Pro Tech Ltd (APT)
ALPHA PRO TECH, LTD. (Alpha Pro Tech), incorporated on June 15, 1994, is in the business of protecting people, products and environments. The Company also manufactures a line of building supply construction weatherization products through its wholly-owned subsidiary, Alpha ProTech Engineered Products, Inc. Its products are sold under the Alpha Pro Tech brand name, as well as under private label. The Company's products are grouped into three business segments: the Building Supply segment, which consists of construction weatherization products, such as housewrap and synthetic roof underlayment, the Disposable Protective Apparel segment, which consists of disposable protective apparel, such as shoecovers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products and the Infection Control segment, which consists of face masks and eye shields.
Building Supply
The Building Supply segment consists of a line of construction supply weatherization products, namely housewrap and synthetic roof underlayment. This line of products is a natural extension of the Company's core capabilities: creating products designed to protect people and environments. The housewrap, under the trademark REX, offers a weather resistant barrier and, to the homeowner, years of lower energy consumption. REX Wrap and REX Wrap Plus are woven and coated polypropylene micro perforated weather resistant barriers, and REX Wrap Fortis is an engineered composite made up of a woven fabric, a monolithic breather film and a non-woven sheet, offering a non-perforated membrane.
Disposable Protective Apparel
The Disposable Protective Apparel segment includes many different styles of disposable products, such as shoecovers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. The products are manufactured by subcontractors in Asia and, to a much lesser extent, a subcontractor in Mexico. Certain products are made using materials supplied by th! e Company.
Infection Control
The Infection Control segment includes face masks and eye shields. The Company's face masks come in a range of filtration efficiencies and styles. The Company's Positive Facial Locka feature provides a custom fit to the face to prevent blow-by for better protection. The Company's Magic Arch feature holds the mask away from the nose and mouth, creating a comfortable breathing chamber.
Kimberly Clark, 3M Company, Johnson & Johnson, White Knight/Precept, Cardinal Health, Inc., Medline Industries Inc., VWR International, LLC, Kimberly Clark, 3M Company, Kappler USA, DuPont and Allegiance Health Care.
Advisors' Opinion:- [By Cindy Bowser]
Alpha Pro Tech (APT) is a Delaware corporation headquartered in Ontario. APT was our ��ompany of the Month��feature in August 2000 at $1.31 per share.
Top 10 Low Price Companies To Own For 2014: Coty Inc (COTY)
Coty Inc., incorporated on January 20, 1995, is engaged in manufacturing, marketing and distribution of women�� and men�� fragrances, color cosmetics and skin and body care related products globally. The Company operates in three segments: Fragrances, Color Cosmetics and Skin & Body Care. The Company�� power brands consist of adidas, Calvin Klein, Chloe, Davidoff, Marc Jacobs, OPI, philosophy, Playboy, Rimmel and Sally Hansen. The Company sells products in each of its segments through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, drug and mass retailers.
The Company�� Fragrance products include a range of men�� and women�� products, with brands associated with fashion designers, celebrities and lifestyle brands. Color Cosmetics products include nail, lip, eye and other facial color products. Skin & Body Care products include shower gels, deodorants, skin care and sun treatment products.
Advisors' Opinion:- [By Jon C. Ogg]
Before you consider this just to be a bit of IPO pondering, take a step back and understand that some of this list membership already has�filed to come public or actually has�made it public recently. Boise Cascade Co. (NYSE: BCC), CDW Corp. (NASDAQ: CDW), Coty Inc. (NYSE: COTY), Global Brass and Copper Holdings Inc. (NYSE: BRSS), Noodles & Company (NASDAQ: NDLS), Restoration Hardware Holdings Inc. (NYSE: RH), Sprouts Farmers Market Inc. (NASDAQ: SFM) and many others are on the list and have made it to the post-IPO stage in the stock market.
- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
Li & Fung(LFUGY) will distribute some of Coty Inc.'s(COTY) key brands in China, including Adidas, Rimmel and Playboy, as part of an agreement between the two companies. The move is part of Coty’s efforts to reorganize its business in China and focus on growing its business in the world’s second largest economy, the company said in a statement Tuesday.
- [By Michael Lewis]
As happens all too often in the markets, an IPO has come out with lots of hype and, ultimately, little in the way of delivered expectations. Women's fragrance giant Coty (NYSE: COTY ) raised one of the largest IPOs in consumer product history last week, earning more than $1 billion. In the days prior, Wall Street played up the IPO in classic fashion -- citing large brand product awareness and celebrity endorsements as cause for investment. While Fools already know this is not a real reason to buy, apparently the market was either inundated with quick-flipping traders, or just unimpressed by the scent of Coty.
Top 10 Low Price Companies To Own For 2014: Ressources Minieres Radisson Inc (RDS)
Ressources Minieres Radisson Inc., formerly Radisson Mining Resources Inc., is in the process of exploring mining properties. The Company has portfolio of four properties, covering a total area of 2,946 hectares. Three of these properties are located in Quebec and one in Ontario. The Company owns a 100% interest in O��rien 576-hectare property. The Company also owns 100% interest in Kewagama 111.7-hectare property. The Company�� O��rien/Kewagama project is located in the Cadillac-Malartic area, within the Abitibi gold belt. It consists of 36 claims covering an area of 729 hectares. The O��rien/Kewagama project lies approximately five kilometer west of Agnico-Eagle�� Lapa gold mine, also centred on the Cadillac Break, and approximately four kilometer southwest of Agnico-Eagle�� Laronde mine, over 3,000 meters (10,000 feet) in depth. Advisors' Opinion:- [By Jim Jubak]
The latest news to make me wonder if the stock has hit a bottom came out in an interview that the CEO of Royal Dutch Shell (RDS) gave to the Financial Times yesterday, April 1. CEO Ben Van Beurden said that in an effort to make a profit in the company�� North American operations, the company had launched ��roject Mosaic��to cut costs in its North American shale operations, by sourcing more equipment from cheaper Asian suppliers.
Top 10 Low Price Companies To Own For 2014: Coronado Biosciences Inc (CNDO)
Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.
TSO
TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.
CNDO-109
CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.
The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Coronado Biosciences (NASDAQ: CNDO ) has received a distressing two-star ranking.
- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's quickly moving within range of triggering a major breakout trade is Coronado Biosciences (CNDO), which is focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock has been hit hard by the bears in 2013, with shares off by 43%.
If you take a look at the chart for Coronado Biosciences, you'll notice that this stock has been uptrending strong since it double bottomed in November, with shares moving higher from its low of $1.25 to its intraday high of $2.58 a share. During that uptrend, shares of CNDO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CNDO within range of triggering a major breakout trade.
Traders should now look for long-biased trades in CNDO if it manages to break out above some key overhead resistance at $2.70 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.97 million shares. If that breakout hits soon, then CNDO will set up to re-fill some of its previous gap down zone from October that started near $7 a share. Some possible upside targets if CNDO gets into that gap with volume are $4 to $5 a share.
Traders can look to buy CNDO off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $2 a share. One can also buy CNDO off strength once it takes out $2.70 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
No comments:
Post a Comment